Digital pathology

Show results for

Unknown (3418)
Genomics (105)
Transcriptomics (60)
Proteomics (13)
Other (12)
Metabolomics (8)
Genomic (3)
Clinical (3)
Methylation profiling (2)
Models (1)

Organisms

Homo sapiens (58)
Mus musculus (25)
Bombyx mori (13)
Onchocerca volvulus (13)
Klebsiella pneumoniae (13)
Musca domestica (13)
Brugia malayi (13)
Schizosaccharomyces pombe (13)
Streptomyces coelicolor A3(2) (13)
Sus scrofa (13)
Human immunodeficiency virus 1 (13)
Oryza sativa Indica Group (13)
Sinorhizobium meliloti BL225C (13)
Vitis (13)
Sus scrofa domesticus (13)
Ostreococcus tauri (13)
Saccharomyces cerevisiae (13)
Synechocystis sp. PCC 6803 (13)
Olavius algarvensis Gamma 1 endosymbiont (13)
Vitis vinifera (13)
Saccharopolyspora erythraea (13)
Staphylococcus aureus (13)
Rattus norvegicus (13)
Rattus rattus (13)
Pseudomonas aeruginosa (13)
Sus scrofa (3)
Danio rerio (2)
Mycobacterium tuberculosis H37Rv (1)
Felis catus (1)
synthetic construct (1)

Organisms

Homo sapiens (45)
Mus musculus (14)
Sus scrofa (2)
Rattus norvegicus (2)
Artemisia ifranensis (1)
Brassica napus (1)
Danio rerio (1)
Felis catus (1)

Repository

ENA (90)
biostudies-arrayexpress (45)
geo (31)
EGA (13)
pride (13)
MetaboLights (8)
dbGaP (3)
BioModels (1)

Tissue

Skin (4)
Brain (3)
Epithelial cell (2)
Cell culture (2)
Barrett's esophagus (1)
Anal canal (1)
Malignant cell (1)
Breast (1)
Keratinocyte (1)
Urine (1)
Heart (1)
Lung (1)
Kidney (1)
Saliva (1)

Disease

Colorectal Neoplasms (2)
Skin melanoma (2)
Alzheimer's disease (2)
Stomach Neoplasms (1)
Anal canal squamous cell carcinoma (1)
Barrett's esophagus (1)
Cutaneous malignant melanoma 1 (1)
Prostate adenocarcinoma (1)
Cardiovascular system disease (1)
Kidney cancer (1)
Breast cancer (1)

Technology Type

Mass Spectrometry (13)
Mass spectrometry (5)
Shotgun proteomics (4)
Mass spectrometry assay (3)
Data-independent acquisition (3)
Bottom-up proteomics (3)
Mass spectrometry imaging (2)
Illumina HiSeq 3000, Illumina HiSeq 2000, Illumina HiSeq 4000, ILLUMINA (1)
All-ion fragmentation (1)
Gel-based experiment (1)

Instrument Platform

Illumina NovaSeq 6000 (6)
Illumina HiSeq 4000 (3)
Liquid Chromatography MS - negative - reverse phase (3)
Illumina HiSeq 2000 (2)
MS Imaging - negative (2)
Liquid Chromatography MS - positive - reverse phase (2)
Maxwell® RSC 48 Instrument (Promega, AS8500) (1)
Transrectal ultrasound-guided systematic sampling of prostate tissue (TRUS biopsy) (1)
STAR v2.5.3a, rpkmforgenes, RSeQC 2.6.1 (1)
Illumina Nextera XT index kits (Set A–D) (1)
Oligo(dT) primer and SuperScript II reverse transcriptase (ThermoFisher Scientific), TapeStation 4200 or 2100 Bioanalyzer with a DNA High Sensitivity chip (Agilent Biotechnologies) (1)
Aria III (BD Biosciences) (1)
HiSeq 2000 (1)
MouseWG-6_V2_0_R3_11278593_A (1)
NA (1)
Ion Torrent Proton (1)
NextSeq 2000 (1)
BGISEQ-500 (1)
NextSeq 550 (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 3000 (1)
NextSeq 500 (1)
MS Imaging - positive (1)
Exactive (1)
MS Imaging - (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2026 (12)
2024 (11)
2022 (11)
2023 (10)
2025 (9)
2015 (6)
2014 (5)
2010 (5)
2020 (4)
2018 (4)
2011 (4)
2019 (3)
2009 (3)
2008 (3)
2021 (2)
2016 (2)
2013 (2)
2017 (1)
2005 (1)

CHEBI ID

CHEBI:545959 (2)
CHEBI:16411 (2)
CHEBI:18183 (2)
CHEBI:4178 (2)
CHEBI:18300 (2)
CHEBI:17859 (2)
CHEBI:9300 (2)
CHEBI:16709 (2)
CHEBI:7916 (2)
CHEBI:30769 (2)
CHEBI:15741 (2)
CHEBI:195171 (1)
CHEBI:17576 (1)
CHEBI:182625 (1)
CHEBI:176874 (1)
CHEBI:80532 (1)
CHEBI:62416 (1)
CHEBI:132423 (1)
CHEBI:79076 (1)
CHEBI:2504 (1)
CHEBI:67205 (1)
CHEBI:16067 (1)
CHEBI:27427 (1)
CHEBI:32802 (1)
CHEBI:10086 (1)
CHEBI:31543 (1)
CHEBI:32303 (1)
CHEBI:80853 (1)
CHEBI:2760 (1)
CHEBI:51312 (1)

Metabolite Name

Pantothenic acid (3)
Homovanillic acid (2)
Betaine (2)
Maleic acid (2)
Malic acid (2)
Serine (2)
Suberic acid (2)
Glutaric acid (2)
Pyroglutamic acid (2)
Coleonol (1)
Erythro-3-Hydroxy-Ls-aspartate (1)
Methyl-9-hydroperoxy-delta10E,12Z-octadecadienoate (1)
FA 18:1+3O (1)
2-[(2-hydroxy-3-methylbutanoyl)amino]-4-methylpentanoic acid (1)
13-HpOTrE(r) (1)
C11-LAS (SAMPLE) (1)
FA 18:2+3O (1)
C11-Las (Standard Mix) (1)
9-Oxo-11-(3-pentyloxiran-2-yl)undec-10-enoic acid (1)
Cyclohomonervilasterol_Cyclohomonervilasterol (1)
5(S)-Hpete (1)
2-Ethylbutanedioic acid (1)
16-hydroxypalmitic acid (1)
C12-Ae1S (Tentative) (1)
N-Glycyl-L-leucine (1)
FA 9:2+1O (1)
3-Amino-Beta-Pinene (1)
7-[(1R,2R,3R)-3-Hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]-5-heptenoic acid (1)
Hydroxyphenyllactate (1)
15-Oxoete (1)

First Public Date

2025 (18)
2022 (16)
2023 (15)
2024 (14)
2026 (9)
2019 (4)
2014 (4)
2013 (3)
2021 (2)
2020 (2)
2018 (2)
2015 (1)

Modelling Approach

Computational model (1)

Study status

Active, not recruiting (1)
Not provided (1)
Recruiting (1)

Lab affiliation

Department of Pathology and Molecular Pathology, University Hospital Zürich and University of Zürich, Zürich, Switzerland (1)
Department of Translational Medicine, Lund University, Sweden (1)
Department of Medical Sciences, Institute of Biomedicine-iBiMED,Univerity of Aveiro, 3810-193 Aveiro,Portugal (1)
Dept of Pharmacology and Immunology Medical University of South Carolina Charleston, SC, USA (1)
Lund University, Dept. Biomedical Engineering (1)
Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain (1)
Department of Translational Medicine, Lund University, Lund Sweden (1)
Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Paul-Wittsack Str. 10, 68163, Mannheim, Germany. Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, 69120 Heidelberg, Germany. Medical Faculty, Heidelberg University, 69120 Heidelberg, Germany. (1)
Department of Pharmacology, University of Nevada, Reno School of Medicine (1)
Prof. Dr. Matthias Mann Max Planck Institute of Biochemistry Am Klopferspitz 18 82152 Martinsried +49 89 8578-2557 (1)
Maastricht MultiModal Molecular Imaging institute (M4i), Maastricht University, The Netherlands (1)
Assistant Professor, Departments of Oncology & Pathology, McGill University Principal Investigator, Cancer Research Program, MUHC-RI 1001 Decarie Blvd, EM2.2218 514.934.1934 ext 76307 Montréal, Canada (1)
IMP - Research Institute of Molecular Pathology Campus-Vienna-Biocenter 1 1030 Vienna Austria (1)

Keyword

Preparation (1)
Patient empowerment (1)
E-health (1)
Tumor resection (1)
Lymphocytic density (1)
CD3 (1)
CD45RO (1)
Genetic feature of the tumor (1)
Image analysis software (1)
Patient engagement (1)
Digital Pathology (1)
Whole Slide Image (1)
Immunoscore (1)
Enhanced recovery (1)
Immunohistochemistry (1)
CD8 (1)
Rehabilitation (1)
Biopsy (1)
Digital health (1)
Relapse (1)
Prehabilitation (1)
Colorectal surgery (1)

IsPrivate

False (1)

Submitter Keywords

FAIR-AIML (1)
Machine Learning Model (1)

Study type

Transcription profiling by array (12)
RNA-seq of coding RNA (11)
RNA-seq of coding RNA from single cells (4)
Unknown experiment type (3)
Animal - High-throughput sequencing (2)
Spatial transcriptomics by high-throughput sequencing (2)
Other (2)
Methylation profiling by array (2)
RNA-seq of non coding RNA (2)
Observational (2)
Capture-C (1)
Comparative genomic hybridization by array (1)
ChIP-seq (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of total RNA (1)
Interventional (1)

Release Date

2025 (588)
2024 (458)
2022 (449)
2023 (446)
2021 (419)
2020 (299)
2019 (177)
2018 (136)
2017 (97)
2026 (96)
2016 (93)
2015 (51)
2014 (42)
2013 (31)
2011 (18)
2009 (15)
2012 (13)
2010 (12)
2008 (9)
2005 (5)
2007 (4)
2003 (2)
2006 (1)
2004 (1)
2000 (1)

Location

France (2)
China (1)

Previous page
1 / 363
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 363
Next page

Sort by:

Relevance

Page size

Current opinion, status and future development of digital pathology in Switzerland.

Not available

S-EPMC9609370 | biostudies-literature

AI-based digital pathology and spatial proteomics enable precision oncology: A case report of recurrent melanoma in a young patient

Background: Metastatic melanoma presents clinical challenges due to tumor heterogeneity and resistance mechanisms, especially when standard treatments fail. Recent advances in artificial intelligence (AI) and spatial proteomics have opened new avenues for precision oncology. Exploring these principl...

ORGANISM(S): Homo sapiens (Human)

2026-09-07 | PXD073928 | Pride